Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2000 Aug;76(4):277–281. doi: 10.1136/sti.76.4.277

The power of information and contraceptive choice in a family planning setting in Mexico

E Ponce 1, N Sloan 1, B Winikoff 1, A Langer 1, C Coggins 1, A Heimburger 1, C Conde-Glez 1, J Salmeron 1
PMCID: PMC1744176  PMID: 11026883

Abstract

Objectives: This study measured the effect of information about family planning methods and STD risk factors and prevention, together with personal choice on the selection of intrauterine devices (IUDs) by clients with cervical infection.

Methods: We conducted a randomised, controlled trial in which family planning clients were assigned to one of two groups, the standard practice (control) group in which the provider selected the woman's contraceptive and the information and choice (intervention) group. The study enrolled 2107 clients in a family planning clinic in Mexico City.

Results: Only 2.1% of the clients had gonorrhoea or chlamydial infections. Significantly fewer women in the intervention group selected the IUD than the proportion for whom the IUD was recommended in the standard care group by clinicians (58.2% v 88.2%, p=0.0000). The difference was even more pronounced among infected women: 47.8% v 93.2% (intervention v control group, p=0.0006).

Conclusions: The intervention increased the selection of condoms and reduced the selection of IUDs, especially among women with cervical infections, for whom IUD insertion is contraindicated.

Key Words: reproductive health; sexually transmitted diseases; contraception

Full Text

The Full Text of this article is available as a PDF (135.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourgeois A., Henzel D., Dibanga G., Malonga-Mouelet G., Peeters M., Coulaud J. P., Fransen L., Delaporte E. Prospective evaluation of a flow chart using a risk assessment for the diagnosis of STDs in primary healthcare centres in Libreville, Gabon. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S128–S132. [PubMed] [Google Scholar]
  2. Braddick M. R., Ndinya-Achola J. O., Mirza N. B., Plummer F. A., Irungu G., Sinei S. K., Piot P. Towards developing a diagnostic algorithm for Chlamydia trachomatis and Neisseria gonorrhoeae cervicitis in pregnancy. Genitourin Med. 1990 Apr;66(2):62–65. doi: 10.1136/sti.66.2.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC) Current trends, IUD safety: report of a nationwide physician survey. 1974. MMWR Morb Mortal Wkly Rep. 1997 Oct 17;46(41):969–974. [PubMed] [Google Scholar]
  4. Chernesky M. A. How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries? Sex Transm Dis. 1997 Feb;24(2):61–63. doi: 10.1097/00007435-199702000-00001. [DOI] [PubMed] [Google Scholar]
  5. Dallabetta G. A., Gerbase A. C., Holmes K. K. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S1–11. [PubMed] [Google Scholar]
  6. Daly C. C., Maggwa N., Mati J. K., Solomon M., Mbugua S., Tukei P. M., Hunter D. J. Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourin Med. 1994 Jun;70(3):155–161. doi: 10.1136/sti.70.3.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farley T. M., Rosenberg M. J., Rowe P. J., Chen J. H., Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992 Mar 28;339(8796):785–788. doi: 10.1016/0140-6736(92)91904-m. [DOI] [PubMed] [Google Scholar]
  8. Faúndes A., Telles E., Cristofoletti M. L., Faúndes D., Castro S., Hardy E. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception. 1998 Aug;58(2):105–109. doi: 10.1016/s0010-7824(98)00064-x. [DOI] [PubMed] [Google Scholar]
  9. Gerbase A. C., Rowley J. T., Heymann D. H., Berkley S. F., Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect. 1998 Jun;74 (Suppl 1):S12–S16. [PubMed] [Google Scholar]
  10. Kooiker C. H., Scutchfield F. D. Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med. 1990 Sep;153(3):279–282. [PMC free article] [PubMed] [Google Scholar]
  11. Lee N. C., Rubin G. L., Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol. 1988 Jul;72(1):1–6. [PubMed] [Google Scholar]
  12. Ory H. W. A review of the association between intrauterine devices and acute pelvic inflammatory disease. J Reprod Med. 1978 Apr;20(4):200–204. [PubMed] [Google Scholar]
  13. Plummer F. A., Laga M., Brunham R. C., Piot P., Ronald A. R., Bhullar V., Mati J. Y., Ndinya-Achola J. O., Cheang M., Nsanze H. Postpartum upper genital tract infections in Nairobi, Kenya: epidemiology, etiology, and risk factors. J Infect Dis. 1987 Jul;156(1):92–98. doi: 10.1093/infdis/156.1.92. [DOI] [PubMed] [Google Scholar]
  14. Ronsmans C., Bulut A., Yolsal N., Agaçfidan A., Filippi V. Clinical algorithms for the screening of Chlamydia trachomatis in Turkish women. Genitourin Med. 1996 Jun;72(3):182–186. doi: 10.1136/sti.72.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vuylsteke B., Laga M., Alary M., Gerniers M. M., Lebughe J. P., Nzila N., Behets F., Van Dyck E., Piot P. Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clin Infect Dis. 1993 Jul;17(1):82–88. doi: 10.1093/clinids/17.1.82. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES